Histophilus somni in Cattle: Thrombotic Meningoencephalitis and BRD Diagnosis

Introduction

Histophilus somni (formerly Haemophilus somnus) is a Gram-negative coccobacillus belonging to the family Pasteurellaceae. It is an opportunistic pathogen of cattle that contributes significantly to the bovine respiratory disease (BRD) complex and is the primary causative agent of thrombotic meningoencephalitis (TME), a rapidly fatal neurologic syndrome. The organism also causes myocarditis, polyarthritis, and reproductive disorders. Accurate diagnosis of H. somni infection is critical for implementing timely antimicrobial therapy and control measures. This article provides a comprehensive clinical and diagnostic reference for Histophilus somni bovine thrombotic meningoencephalitis BRD diagnosis, covering etiology, epidemiology, pathogenesis, clinical signs, pathologic findings, and both conventional and molecular laboratory detection methods.

Etiology and Taxonomy

Histophilus somni is a fastidious, nonmotile, pleomorphic coccobacillus. It requires a CO2-enriched atmosphere (5–10%) for primary isolation and grows poorly on conventional media. Colonies on chocolate agar appear as small, grayish, nonhemolytic to weakly beta-hemolytic after 24–48 hours. The bacterium produces a polysaccharide capsule and expresses several virulence factors, including lipooligosaccharide (LOS), immunoglobulin-binding proteins, and an exopolysaccharide that contributes to biofilm formation.

Phylogenetic analyses place H. somni within the same clade as Mannheimia haemolytica and Pasteurella multocida, but the organism is genetically distinct. Molecular typing using 16S rRNA sequencing and multilocus sequence typing (MLST) reveals considerable strain heterogeneity, with certain strains associated with respiratory disease and others with systemic infections such as TME.

Epidemiology

Histophilus somni is a commensal of the upper respiratory tract and reproductive tract of cattle. Carrier rates in healthy herds range from 10% to 50%. Stressors such as transport, commingling, viral infections (e.g., bovine respiratory syncytial virus, bovine herpesvirus-1), and adverse weather precipitate shedding and transmission. The bacterium spreads via direct contact, nasal secretion aerosols, and fomites. Calves aged 2–10 months are most susceptible, particularly in feedlot settings where BRD incidence is highest.

Coinfection with other BRD pathogens is common. A study in yaks (Bos grunniens) using deep nasal swabs and multiplex PCR (mPCR) reported that 4.6% of samples were positive for H. somni, with frequent concurrence of M. haemolytica (14.6%) and P. multocida (1.2%) [1]. This demonstrates the importance of molecular syndromic diagnosis for BRD.

Pathogenesis and Thrombotic Meningoencephalitis (TME)

The pathogenesis of H. somni involves adherence to respiratory epithelium, evasion of host defenses, and systemic dissemination. The bacterial LOS triggers a strong inflammatory response, leading to endothelial damage and intravascular coagulation. In TME, the organism enters the bloodstream and localizes in the central nervous system microvasculature. The resulting thrombotic lesions obstruct small arteries and capillaries, causing ischemia, infarction, and liquefactive necrosis of brain tissue.

The classic TME lesion is a fibrinocellular thrombus within cerebral arterioles, accompanied by perivascular edema, neutrophil infiltration, and gliosis. The thalamus, midbrain, and basal ganglia are most frequently affected. The animal develops progressive neurologic deficits, often culminating in recumbency and death within 24–72 hours if untreated.

Clinical Signs

Clinical manifestations of H. somni infection vary depending on the affected organ system.

Respiratory form (BRD): Fever (40–42°C), nasal discharge, cough, tachypnea, dyspnea, and increased lung sounds. This presentation is indistinguishable from other bacterial pneumonias (e.g., M. haemolytica, P. multocida, Trueperella pyogenes). Chronic cases may progress to fibrinous pleuropneumonia with pleural adhesions.

Thrombotic meningoencephalitis (TME): Sudden onset of depression, ataxia, circling, head pressing, nystagmus, bilateral or unilateral blindness, recumbency, and convulsions. Hyperesthesia and opisthotonos are common. Morbidity is low (1–5%) but case fatality rate approaches 100% without intervention.

Myocarditis: Arrhythmias, sudden death, and pulmonary edema. This form is often subclinical and discovered at necropsy.

Polyarthritis and reproductive disease: Lameness, swollen joints (carpus, tarsus, stifle), and abortion or endometritis in cows.

Pathology

Gross lesions in TME: Unilateral or bilateral areas of malacia in the brain, often in the thalamus, midbrain, and basal ganglia. Lesions appear yellow-brown, soft, and hemorrhagic on cut section. The meninges may be congested but not suppurative.

Gross lesions in respiratory form: Cranioventral consolidation of the lung lobes, fibrinous exudate on pleural surfaces, and interlobular edema. Areas of necrosis and abscessation are less common than in M. haemolytica pneumonias.

Myocardial lesions: Focal or multifocal necrotic foci, often in the left ventricular wall, progressing to abscess formation.

Histopathology: Characteristic necrotizing vasculitis with fibrin thrombi in small arteries. In the lung, bronchiolitis obliterans with peribronchiolar lymphoid hyperplasia can be observed.

Diagnosis of Histophilus somni Bovine Thrombotic Meningoencephalitis and BRD

Accurate diagnosis requires a combination of clinical assessment, necropsy findings, and laboratory confirmation. Because H. somni is fastidious, molecular methods offer superior sensitivity over culture.

Sample Collection and Transport

• Nasal or nasopharyngeal swabs: Use deep nasal swabs or guarded swabs. Place in Amies transport medium with charcoal and transport at 4°C within 24 hours.
• Tissues: Lung, brain (Thalamus, midbrain), and joint fluid. Collect in sterile containers and refrigerate.
• Blood culture: Draw aseptically from symptomatic febrile animals; inoculate into commercial blood culture bottles.

Culture and Identification

Inoculate onto chocolate agar or Columbia blood agar supplemented with 5% sheep blood and 0.5% yeast extract. Incubate at 35–37°C in 5–10% CO2 for 24–48 hours. Colonies are small, opaque, and nonhemolytic. Gram stain: Gram-negative coccobacilli (pleomorphic). Biochemical profiles: positive for oxidase, catalase, and alkaline phosphatase; negative for urease and indole. Commercial identification kits (e.g., API NH) can confirm but require careful interpretation due to variable strain reactions.

Limitations: Culture sensitivity is low (approximately 40–60%) due to antimicrobial therapy prior to sampling, overgrowth by commensal flora, and fastidious growth requirements.

Molecular Detection

Polymerase chain reaction (PCR) targeting the 16S rRNA gene or species-specific genes (e.g., the lppB gene encoding a lipoprotein) provides high sensitivity and specificity. Multiplex PCR assays that simultaneously detect H. somni, M. haemolytica, P. multocida, and Mycoplasma bovis are widely used for syndromic BRD diagnosis. In the yak pilot study, mPCR detected H. somni in 4.6% of samples compared to only 1.3% by culture [1], illustrating the diagnostic advantage.

Real-time qPCR can quantify bacterial load, which may correlate with disease severity. Samples can be nasal swabs, bronchoalveolar lavage, or fresh tissue homogenates. PCR inhibitors in nasal mucus and blood should be controlled with internal amplification controls.

Table 1: Comparison of Diagnostic Methods for H. somni

Differential Diagnoses

• TME: Listeria monocytogenes (circling disease, microabscesses in brainstem), pyogenic meningitis (e.g., Trueperella pyogenes), polioencephalomalacia (thiamine deficiency), lead poisoning.
• Respiratory form: M. haemolytica, P. multocida, Mycoplasma bovis, Bovine coronavirus, Bovine respiratory syncytial virus, Bovine herpesvirus-1.

Diagnostic Algorithm

flowchart TD
    A[Clinical Signs: Neurologic / Respiratory / Acute Death], > B[Collect Samples: Deep nasal swab, CSF, brain or lung tissue, joint fluid]
    B, > C[Initial Workup: Gram stain, cytology, clinical pathology (CSF analysis: increased protein, neutrophils)]
    C, > D{Perform PCR (multiplex if available)}
    D, Positive for H. somni, > E[Consider H. somni as primary or contributing pathogen]
    D, Negative or Indeterminate, > F[Attempt Culture (chocolate agar, CO2 enrichment)]
    F, Growth, > G[Confirm H. somni: Biochemical or MALDI-TOF]
    F, No Growth, > H[Consider histopathology if tissue available: characteristic vasculitis/thrombi]
    E, > I[Initiate antimicrobial therapy + supportive care]
    G, > I
    H, > I

Treatment

H. somni is generally susceptible to beta-lactam antibiotics (penicillin, ceftiofur), fluoroquinolones (enrofloxacin, danofloxacin), macrolides (tulathromycin, gamithromycin), and tetracyclines (oxytetracycline). However, antimicrobial susceptibility testing is recommended due to emerging resistance patterns (e.g., against tetracyclines). Early treatment is critical for TME: administer high-dose ceftiofur or enrofloxacin intravenously, combined with nonsteroidal anti-inflammatory drugs (flunixin meglumine) to reduce inflammation and endotoxemia.

For BRD, metaphylactic administration of long-acting macrolides or fluoroquinolones upon feedlot arrival has been used, although judicious use is urged to mitigate antimicrobial resistance. Treatment failure should prompt re-culture and susceptibility testing.

Control and Prevention

Control strategies focus on reducing stress, improving ventilation, implementing all-in/all-out management, and vaccination.

Vaccination: Commercial bacterins are available; they provide partial protection against respiratory disease but are less effective against TME. Autogenous vaccines may be used in herds with persistent problems.

Management: Avoid overcrowding, ensure adequate colostrum intake (passive antibodies reduce risk), and separate age groups. Viral vaccination against BHV-1 and BRSV can decrease predisposing respiratory viral infections.

Biosecurity: Quarantine newly arrived cattle and monitor for signs of BRD. Promptly isolate and treat affected animals.

Conclusion

Histophilus somni remains an important bacterial pathogen in cattle, causing significant economic losses through respiratory disease and fatal thrombotic meningoencephalitis. The diagnosis of Histophilus somni bovine thrombotic meningoencephalitis BRD diagnosis relies heavily on molecular methods, particularly multiplex PCR, which outperforms culture in sensitivity and turnaround time. Recognition of the characteristic neurologic signs and prompt therapeutic intervention are essential to reduce mortality. Continued surveillance of antimicrobial resistance and development of more effective vaccines are needed to control this pathogen in modern cattle production systems.

References

[1] Sahay S, Jayaram PKP, Natesan K, et al. Respiratory infections in yak (Bos grunniens): a pilot study on isolation and direct PCR diagnosis for pasteurellosis, mannheimiosis and histophilosis. Indian Journal of Animal Sciences. 2018. Available at: https://www.semanticscholar.org/paper/e1671ec1ad4a4293fc1da68bb56376dbe127ed90